Q: Could I please have your comments on the MONANTIK announcement and its affect if any on the stock.
Thank You.
Thank You.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi 5i - I'm seeing a trailing P/E of 2.2. Is that correct? Is it that undervalued?
Thx as always.
Thx as always.
Q: Hello 5i just wondering when GUD earning are coming out, appreciate all your help
Q: Good Morning
Since November 29, 2016 there were no insider buyers in this Company just sellers. Furthermore, both the CEO and CFO reduced their positions by 2,000,000 shares each during the last year.
Is this cause for concern?
Thank you
Since November 29, 2016 there were no insider buyers in this Company just sellers. Furthermore, both the CEO and CFO reduced their positions by 2,000,000 shares each during the last year.
Is this cause for concern?
Thank you
Q: Savaria has announced a $1.1m contract in China. The share price has responded quite well. A $1.1m contract is not “huge” but if they do a good job executing it doors may open.
China has the potential to be a “huge” market.
Your thoughts?
China has the potential to be a “huge” market.
Your thoughts?
Q: I've held Cynosure (CYNO) for a few years and it recently received an all cash offer for $66 a share; however, now some law firm has come out questioning "whether the Company’s Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company’s shares of common stock."
The stock went has high as $66.65 on the news but is currently hovering just above $66.
In these types of situations does this often result in a higher offer? I am tempted to hold and see what happens if there is essentially no risk but I would also like to sell now to get the cash. What would you do?
The stock went has high as $66.65 on the news but is currently hovering just above $66.
In these types of situations does this often result in a higher offer? I am tempted to hold and see what happens if there is essentially no risk but I would also like to sell now to get the cash. What would you do?
Q: ANY CONSIDERATION ABOUT THIS COMPANY?
Q: Is this a good time to buy GUD?I already has half a position.Appreciate u normal great services & opinions
Q: Just wandering if you had any idea why there was a sharp pullback today in the face of a fairly decent quarterly report.Also would you look at adding now,I have a .75% position currently in the stock thanks
Q: Could you please give me your analysis of Parex' results just announced today. Thank you.
Q: do you think the valuation has gotten to high that it might be time to switch into something else
Q: thoughts on earnings
Q: What do you think now of Valiant Pharmaceuticals?
It is at its lowest 52 week low. Its market cap is still 5.35 Billion.
Is it recommended for a buy and hold for at least a year?
It is at its lowest 52 week low. Its market cap is still 5.35 Billion.
Is it recommended for a buy and hold for at least a year?
Q: Mr. Hodson, I appreciate your response to Stephen today regarding GUD. When do you expect the weakness to stop ?
Q: Any explanation for GUD's weakness the past couple of days?
Q: I've enjoyed a quick run-up on TH. It now represents an 8% portfolio weight. My questions is two parts. First, could you comment on their prospects? Their earnings should be growing and they are adding a drug to their offering. As a thing trader, there could be a big run-up as the story gains traction.
Second, in a case like this where there is a quick run-up and the portfolio weighting becomes large, when is it time to trim? It seems to me that using portfolio weight as your only guide could mean missing big gains if you're early on a good company.
Second, in a case like this where there is a quick run-up and the portfolio weighting becomes large, when is it time to trim? It seems to me that using portfolio weight as your only guide could mean missing big gains if you're early on a good company.
Q: Hello. How does the 5I team rate the quality of the management of PLI? Has PLI also given any indication of product releases for 2017 given that their drug tests favourably in all tests and has orphan drug status?
Thank You
Clarence
Thank You
Clarence
Q: Guys, great site, great job. Can you comment on CVR Medical Corp.
Q: Hi,Any insights here. Looks like they may be on to something.
Thanks
G
Thanks
G
Q: Thinking of this one in replacement of GILD that i sold 2 weeks ago. low p/e and peg, nice dividend but high debt.Argus and S&P by applying comp p/e come up with a target of 84$. Does it deserve the p/e or cheap for a reason?
What is your view on this one ?
Any suggestion ?
(like everybody else: I know you don't cover US stocks... bla bla bla)
Thanks much!
What is your view on this one ?
Any suggestion ?
(like everybody else: I know you don't cover US stocks... bla bla bla)
Thanks much!